The MRC WIMM community gathered for its flagship annual event, WIMM Day, on Tuesday 24th June. Held at the Sa\u00efd Business School, the day showcased the breadth and impact of research across the institute and celebrated achievements in mentorship, public engagement and more.
Researchers at the University of Oxford have uncovered a potential new therapeutic target in a particularly aggressive and hard-to-treat form of leukaemia.
A new study, led by researchers at the MRC TIDU in the MRC Weatherall Institute of Molecular Medicine, NDM's CAMS Oxford Institute, the Centre for Human Genetics, the Kennedy Institute and the Dunn School of Pathology, has found that specific T cells could have an impact on the long-term protective responses to future infection.
Researchers in Oxford have found structures of immune cells in the gut that may be driving the response to gluten in people with coeliac disease and could provide a target for future therapies.
Four academics from the University of Oxford have been elected to the National Academy of Sciences in the US this year as international members, including former Institute Director Andrew McMichael.
Professor Adam Mead is Editor-in-Chief and Graham Collins and Deborah Hay two of the editors for the eighth edition of this key reference work, now in its sixth decade.
A new study led by the Fairfax Group at the University of Oxford has revealed that a common and usually harmless virus may positively influence how skin cancer patients respond to current treatments.
Facility Manager Michalina Mazurczyk, based in the MRC Weatherall Institute of Molecular Medicine, has been appointed as Technician Champion for the second year.
Professor Oliver Bannard has been awarded funding for an 8-year research programme investigating how our immune systems establish antibody-mediated immunity following vaccination and during infection.
An international collaboration, initiated by the Jackson Group at the MRC WIMM, has uncovered new information that could help in the development of drugs to block conditions such as autoimmunity and inflammation.
A collaboration between the Drakesmith and Higgs Groups at the MRC WIMM has identified an ancient connection between metabolic and transcriptional control of erythropoiesis.
Associate Professor Adam Wilkinson has received the 2025 Janet Rowley Award from the International Society for Experimental Haematology for his outstanding contributions in the field of hematopoietic stem cell biology.
For International Women's Day on 8th March 2025, women from the MRC WIMM reflect on why this day is so important, the barriers and biases women can face in their careers, and which women have inspired them.
![\"\"](\"https://www.imm.ox.ac.uk/news/wimm-day-2025/responsive_image?ratio=r16x9&scale=w760\")
\n \n \n\n\n